C
Christina Daousi
Researcher at University of Liverpool
Publications - 61
Citations - 2587
Christina Daousi is an academic researcher from University of Liverpool. The author has contributed to research in topics: Insulin resistance & Population. The author has an hindex of 25, co-authored 58 publications receiving 2213 citations. Previous affiliations of Christina Daousi include Aintree University Hospitals NHS Foundation Trust & Queen Mary University of London.
Papers
More filters
Journal ArticleDOI
Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes
TL;DR: A cross‐sectional study has been performed in order to estimate the prevalence, severity, and current treatment of chronic painful peripheral neuropathy in people with diabetes in the community.
Journal ArticleDOI
Prevalence of obesity in type 2 diabetes in secondary care: association with cardiovascular risk factors.
Christina Daousi,I.F. Casson,Geoff Gill,Ian A. MacFarlane,John P.H. Wilding,Jonathan Pinkney +5 more
TL;DR: Obese patients with type 2 diabetes were younger, had poorer glycaemic control, higher blood pressures, worse lipid profiles, and were more likely to be receiving antihypertensive and lipid lowering drugs compared with patients with BMI <30 kg/m2.
Journal ArticleDOI
Improved Glycaemia Correlates with Liver Fat Reduction in Obese, Type 2 Diabetes, Patients Given Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists
Daniel J. Cuthbertson,Andrew J. Irwin,Chris J Gardner,Christina Daousi,Tej Purewal,Niall Furlong,Niru Goenka,E. Louise Thomas,V.L. Adams,Sudeep Pushpakom,Munir Pirmohamed,Graham J. Kemp +11 more
TL;DR: The impact of 6 months’ GLP-1 RA therapy on intrahepatic lipid (IHL) in obese, T2DM patients with hepatic steatosis was determined and the inter-relationship between changes in IHL with those in glycosylated haemoglobin, body weight, and volume of abdominal visceral and subcutaneous adipose tissue was evaluated.
Journal ArticleDOI
Polycystic Ovary Syndrome with Hyperandrogenism Is Characterized by an Increased Risk of Hepatic Steatosis Compared to Nonhyperandrogenic PCOS Phenotypes and Healthy Controls, Independent of Obesity and Insulin Resistance
Helen Jones,Victoria S. Sprung,Christopher J. A. Pugh,Christina Daousi,Andrew J. Irwin,Nabil Aziz,V.L. Adams,E. Louise Thomas,Jimmy D. Bell,Graham J. Kemp,Daniel J. Cuthbertson +10 more
TL;DR: It is suggested that HA-PCOS is associated with hepatic steatosis, independent of obesity and insulin resistance, in women with polycystic ovary syndrome.
Journal ArticleDOI
Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients
Eleni Daniel,Simon Aylwin,Omar G Mustafa,Steve Ball,Steve Ball,Atif Munir,Kristien Boelaert,Vasileios Chortis,Daniel J. Cuthbertson,Christina Daousi,Surya Panicker Rajeev,Julian R. E. Davis,Kelly Cheer,William Drake,Kirun Gunganah,Ashley B. Grossman,Mark Gurnell,Andrew S Powlson,Niki Karavitaki,Niki Karavitaki,Isabel Huguet,Tara Kearney,Kumar Mohit,Karim Meeran,Neil E. Hill,Aled Rees,Andrew Lansdown,Peter J Trainer,Anna-Elisabeth H Minder,John Newell-Price +29 more
TL;DR: Metyrapone is effective therapy for short- and long-term control of hypercortisolemia in CS and has shown significant improvements on metyrapone, first evaluation to last review.